Shanrong Biotechnology Corp.
SRBT
$0.3216
-$0.3284-50.52%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -5.08M | -2.04M | -2.75M | -2.73M | -2.72M |
| Total Depreciation and Amortization | 35.60K | 35.60K | 35.60K | 35.60K | 35.60K |
| Total Amortization of Deferred Charges | -- | 2.50K | 10.00K | 17.50K | 25.00K |
| Total Other Non-Cash Items | 3.38M | 62.80K | 21.50K | 83.20K | 127.20K |
| Change in Net Operating Assets | 872.40K | 1.10M | 1.52M | 1.49M | 1.08M |
| Cash from Operations | -787.40K | -836.70K | -1.17M | -1.10M | -1.46M |
| Capital Expenditure | -- | -1.00K | -1.00K | -1.00K | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 3.70K | 7.90K | 0.00 | 0.00 |
| Cash from Investing | 0.00 | 2.70K | 6.90K | -1.00K | -1.00K |
| Total Debt Issued | 229.40K | 619.70K | 875.50K | 1.24M | 2.25M |
| Total Debt Repaid | -107.60K | -420.70K | -354.00K | -619.10K | -1.14M |
| Issuance of Common Stock | 635.00K | 560.00K | 650.00K | 650.00K | 400.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -25.00K |
| Cash from Financing | 756.70K | 759.00K | 1.17M | 1.27M | 1.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -30.70K | -75.00K | 9.20K | 166.90K | 27.00K |
